Canadian Cancer Trials Group Bulletins


Maria Ricci Memorial Lectureship in Medical Oncology

Dr. Karen Gelmon was the inaugural speaker for the Maria Ricci Memorial Lectureship in Medical Oncology held 13 November 2008 at the Cancer Research Institute, Queen's University. The title of Dr. Gelmon's talk was "The Hit and Miss of Targeted Therapy for Breast Cancer".

Approximately 100 faculty, staff and students were in attendance, as well as three representatives from GlaxoSmithKline who travelled from Toronto for the lecture to commemorate their colleague, Maria Ricci.

Maria was GlaxoSmithKline's Scientific Development Manager in oncology when her life ended tragically in January 2007 while traveling on GSK-related business. She was committed to making a difference for Canadian patients. Maria was instrumental in bridging relationships between global GSK and the Canadian medical community and facilitated Canadian scientific and medical engagement in the development of GSK's oncology pipeline.

Maria was well respected by her colleagues and peers and remembered for her enthusiasm and passionate approach to work and life. She was a PhD candidate in Microbiology & Immunology at McGill University and received her MSc in pharmacology and toxicology from the University of Western Ontario.

The Maria Ricci Memorial Lectureship in Medical Oncology was established in 2007 with funding provided by GlaxoSmithKline Inc. in memory of Maria Ricci. The proceeds of this endowment will be used to support this lectureship at the Canadian Cancer Trials Group in the area of medical oncology.

From left to right: Patricia de los Rios, Sharon Vantyghem, Diane Drolet (all from GSK) and Dr. Karen Gelmon.